REFERENCES

1. Choi KS, Scorpio DG, Dumler JS. Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation.

2. Brian JE Jr, Faraci FM. Tumor necrosis factor-alpha-induced dilata­tion of cerebral arterioles. Stroke 1998;29:509-15.

3. van Deuren M, Dofferhoff AS, van der Meer JW. Cytokines and the response to infection. J Pathol 1992;168:349-56.

4. Eschenbach DA. Amniotic fluid infection and cerebral palsy. Focus on the fetus. JAMA 1997;278:247-48.

5. Goldenberg RL, Hauth JC, Andrews WW Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-507.

6. Yoon BH, Romero R, Kim CJ, et al. High expression oftumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-11.

7. Saija A, Princi P, Lanza M, Scalese M, Aramnejad E, De Sarro A. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci 1995;56:775-84.

8. Wright JL, Merchant RE. Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. J Neurooncol 1994;20:17-25.

9. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci 1995;18:83-88.

10. Robbins DS, Shirazi Y, Drysdale BE, Lieberman A, Shin HS, Shin ML. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 1987;139:2593-97.

11. Kahn MA, De Vellis J. Regulation of an oligodendrocyte pro­genitor cell line by the interleukin-6 family of cytokines. Glia 1994;12:87-98.

12. Andrews T, Zhang P, Bhat NR. TNFalpha potentiates IFNgamma- induced cell death in oligodendrocyte progenitors. J Neurosci Res 1998;54:574-83.

13. Almeida A, Bolanos JP, Medina JM.

14. Altman DI, Powers WJ, Perlman JM, Herscovitch P, Volpe SL, Volpe JJ. Cerebral blood flow requirement for brain viability in newborn infants is lower than in adults. Ann Neurol 1988;24:218-26.

15. Pryds O, Greisen G, Lou H, Friis H. Vasoparalysis associ­ated with brain damage in asphyxiated term infants. J Pediatr 1990;117:119-25.

16. Boylan GB, Young K, Panerai RB, Rennie JM, Evans DH. Dynamic cerebral autoregulation in sick newborn infants. Pediatr Res 2000;48:12-17.

17. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 1993;13:1441-53.

18. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation- dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1988;18:6241-53.

19. Paneth N, Rudelli R, Kazam E, Monte W Prognosis. In: Brain Damage in the Preterm Infant, pp. 171-185. London: MacKeith; 1994.

20. Volpe JJ. Neurobiology of periventricular leukomalacia in the pre­mature infant. Pediatr Res 2001;50:553-62.

21. Yoon BH, Kim CJ, Romero R, et al. Experimentally induced intra­uterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 1997;177:797-802.

22. Debillon T, Gras-Leguen C, Verielle V, et al. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res 2000;47:736-42.

23. Perlman JM, Risser R, Broyles RS. Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. Pediatrics 1996;97:822-27.

24. Zupan V, Gonzalez P, Lacaze-Masmonteil T, et al. Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol 1996;38:1061-67.

25. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cere­bral palsy: a meta-analysis. JAMA 2000;284:1417-24.

26. De Felice C, Toti P, Laurini RN, et al. Early neonatal brain injury in histologic chorioamnionitis. J Pediatr 2001;138:101-104.

27. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentra­tions in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-40.

28. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.

29. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (inter­leukin-6, tumor necrosisfactor-alpha, interleukin-1 beta,and inter­leukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-30.

30. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-am- niotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675-81.

31. Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995;22:281-342.

32. Sarnat HB. Role of human fetal ependyma. Pediatr Neurol 1992;8:163-78.

33. Morales WJ. The effect of chorioamnionitis on the develop­mental outcome of preterm infants at one year. Obstet Gynecol 1987;70:183-86.

34. Salafia CM, Minior VK, Rosenkrantz TS, et al. Maternal, pla­cental, and neonatal associations with early germinal matrix/ intraventricular hemorrhage in infants born before 32 weeks’ ges­tation. Am J Perinatol 1995;12:429-36.

35. Yoon BH, Romero R, Kim CJ, et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995;172:960-70.

36. Fox H. Infections and inflammatory lesions of the placenta.

37. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.

38. Garcia-Fernandez N, Montes R, Purroy A, Rocha E. Hemostatic disturbances in patients with systemic inflammatory response syndrome (SIRS) and associated acute renal failure (ARF). Thromb Res 2000;100:19-25.

39. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997;278:207-11.

40. Badawi N, Kurinczuk JJ, Keogh JM, et al. Antepartum risk factors for newborn encephalopathy: the Western Australian case-con­trol study. BMJ 1998;317:1549-53.

41. Badawi N, Kurinczuk JJ, Keogh JM, et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-con­trol study. BMJ 1998;317;1554-58.

42. Verma U, Tejani N, Klein S, et al. Obstetric antecedents of intraventricular hemorrhage and periventricular leukomalacia in the low-birth-weight neonate. Am J Obstet Gynecol 1997;176:275-81.

43. Nelson KB, Willoughby RE. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000;13:133-39.

44. Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999.94;274-78.

45. Williams MC, Brien WF, Nelson RN, Spellacy WN. Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants. Am J Obstet Gynecol 2000;183:1094-99.

46. Toti P, De F, Palmeri ML, Villanova M, Martin JJ, Buonocore G. Inflammatory pathogenesis of cortical polymicrogyria: an aut­opsy study. Pediatr Res 1998;44:291-96.

47. Wu YW, Colford JM, Jr. Chorioamnionitis as a risk factor for cere­bral palsy: a meta-analysis. JAMA 2000;284;1417-24.

48. Wu YW, Escobar GJ, Grether JK, et al. Chorioamnionitis and cere­bral palsy in term and near term infants. JAMA 2003;290:2677-84.

49. Banerjee S, Cashman P, Yentis SM, Steer PJ.

50. Impey LW, Greenwood CE, Black RS, Yeh PS, Sheil O, Doyle P. The relationship between intrapartum maternal fever and neo­natal acidosis as risk factors for neonatal encephalopathy. Am J Obstet Gynecol 2008;198:49.e1-6.

51. Macaulay JH, Bond K, Steer PJ. Epidural analgesia in labor and fetal hyperthermia. Obstet Gynecol 1992;80:665-69.

52. Dietrich WD, Busto R, Valdes I, Loor Y. Effects of normothermic versus mild hyperthermic forebrain ischemia in rats. Stroke 1990;21:1318-25.

53. Dietrich WD, Busto R, Halley M, Valdes I. The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia. J Neuropathol Exp Neurol 1990;49:486-97.

54. Lieberman E, Eichenwald E, Mathur G, Richardson D, Heffner L, Cohen A. Intrapartum fever and unexplained seizures in term infants. Pediatrics 2000;106:983-88.

55. Beloosesky R, Weiner Z, Khativ N, et al. Prophylactic maternal N- acetylcysteine before lipopolysaccharide suppresses fetal inflam­matory cytokine responses. Am J Obstet Gynecol 2009;200:665. e1-5.

56. Paintlia MK, Paintlia AS, Contreras MA, Singh I, Singh AK. Lipopolysaccharide-induced peroxisomal dysfunction exacer­bates cerebral white matter injury: attenuation by N-acetyl cyst­eine. Exp Neurol 2008;210:560-76.

57. Buhimschi IA, Buhimschi CS, Weiner CP. Protective effect of N- acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol 2003;188:203-208.

58. Fewell JE, Johnson P. Upper airway dynamics during breathing and during apnoea in fetal lambs. J Physiol 1983;339:495-504.

59. Harding R, Bocking AD, Sigger JN. Upper airway resistances in fetal sheep: the influence of breathing activity. J Appl Physiol 1986;60:160-65.

60. Kalache KD, Chaoui R, Bollmann R. Doppler assessment of tra­cheal and nasal fluid flow during fetal breathing movements: pre­liminary observations.

61. Kalache KD, Chaoui R, Marcks B, et al. Differentiation between human fetal breathing patterns by investigation of breathing- related tracheal fluid flow velocity using Doppler sonography. Prenat Diagn 2000;20:45-50.

62. Kalache KD, Chaoui R, Marks B, et al. Does fetal tracheal fluid flow during fetal breathing movements change before the onset of labour? BJOG 2002;109:514-19.

63. Boddy K, Dawes GS. Fetal breathing. BrMedBull 1975;31:3-7.

64. Patrick JE, Dalton KJ, Dawes GS. Breathing patterns before death in fetal lambs. Am J Obstet Gynecol 1976;125:73-78.

65. Manning FA, Martin CB Jr, Murata Y, et al. Breathing movements before death in the primate fetus (Macaca mulatta). Am J Obstet Gynecol 1979;135:71-76.

66. Byrne DL, Gau G. In utero meconium aspiration: an unprevent­able cause of neonatal death. Br J Obstet Gynaecol 1987;94:813-14.

67. Burgess AM, Hutchins GM. Inflammation of the lungs, umbilical cord and placenta associated with meconium passage in utero. Review of123 autopsied cases. Pathol Res Pract 1996; 192:1121-28.

68. Kearney MS. Chronic intrauterine meconium aspiration causes fetal lung infarcts, lung rupture, and meconium embolism. Pediatr Dev Pathol 1999;2:544-51.

69. Mortensen E, Kearney MS. Meconium aspiration in the midtrimester fetus: an autopsy study. Pediatr Dev Pathol 2009;12:438-42.

70. Eidelman AI, Nevet A, Rudensky B, et al. The effect of meconium staining of amniotic fluid on the growth of Escherichia coli and group B streptococcus. J Perinatol 2002;22:467-71.

71. Florman AL, Teubner D. Enhancement of bacterial growth in am­niotic fluid by meconium. J Pediatr 1969;74:111-14.

72. Larsen B, Galask RP. Host resistance to intraamniotic infection. Obstet Gynecol Surv 1975;30:675-91.

73. Hoskins IA, Hemming VG, Johnson TR, et al. Effects of alter­ations of zinc-to-phosphorus ratios and meconium content on group B Streptococcus growth in human amniotic fluid in vitro. Am J Obstet Gynecol 1987;157:770-73.

74. Clark P, Duff P. Inhibition of neutrophil oxidative burst and phago­cytosis by meconium. Am J Obstet Gynecol 1995;173:1301-305.

75. Romero R, Yoon BH, Chaemsaithong P, et al. Bacteria and endo­toxin in meconium-stained amniotic fluid at term: could intra- amniotic infection cause meconium passage? J Matern Fetal Neonatal Med 2014;27:775-88.

76. Wu JM, Yeh TF, Wang JY, et al. The role of pulmonary inflamma­tion in the development of pulmonary hypertension in newborn with meconium aspiration syndrome (MAS). Pediatr Pulmonol Suppl 1999;18:205-208.

77. Kallapur SG, Nitsos I, Moss TJ, et al. IL-1 mediates pulmonary and systemic inflammatory responses to chorioamnionitis induced by lipopolysaccharide. Am J Respir Crit Care Med 2009;179:955-61.

78. Kallapur SG, Kramer BW, Nitsos I, et al. Pulmonary and systemic inflammatory responses to intra-amniotic IL-1 alpha in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011;301:L285-95.

79. Ban R, Ogihara T, Mori Y, Oue S, Ogawa S, Tamai H. Meconium aspiration delays normal decline of pulmonary vascular resistance shortly after birth through lung parenchymal injury. Neonatology 2011;99:272-79.

80. Jobe AH. Effects of chorioamnionitis on the fetal lung. Clin Perinatol 2012;39:441-57.

81. Lee J, Romero R, Lee KA, et al. Meconium aspiration syndrome: a role for fetal systemic inflammation. Am J Obstet Gynecol 2016;214:366.e1-9.

82. Ugwumadu A. Understanding cardiotocographic patterns asso­ciated with intrapartum fetal hypoxia and neurologic injury. Best Pract Res Clin Obstet Gynaecol 2013;27:509-36.

83. Blot P, Milliez J, Breart G, et al. Fetal tachycardia and meco­nium staining: a sign of fetal infection. Int J Gynaecol Obstet 1983;21:189-94.

84. Maberry MC, Ramin SM, Gilstrap LC 3rd, Leveno KJ, Dax JS. Intrapartum asphyxia in pregnancies complicated by intra-amni- otic infection. Obstet Gynecol 1990;76:351-54.

85. Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988;158:819-28.

86. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymp­tomatic women with abnormal vaginal flora and bacterial vagin­osis: a randomised controlled trial. Lancet 2003;361:983-88.

87. Lamont RF, Duncan SL, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003;101:516-22.

88. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 1991;77: 604-10.

89. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophy­laxis. N Engl J Med 1986;314:1665-69.

90. Gardner SE, Yow MD, Leeds LJ, et al. Failure of penicillin to eradi­cate group B streptococcal colonisation in the pregnant woman. A couple study. Am J Obstet Gynecol 1979;135:1062-65.

91. Hall RT, Barnes W, Krishnan L, et al. Antibiotic treatment of par­turient women colonized with group B streptococci. Am J Obstet Gynecol 1976;124:630-34.

92. White K, Rainbow J, Johonson S, et al. Early onset group B strepto­coccal disease, US 1998-1999. MMWR 2000;49:793-996.

93. Regan JA, Klebanoff MA, Nugent RP, et al. Colonisation with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996;174:1354-60.

94. Schrag SJ, Zell ER, Lynfield R, et al. A population-based com­parison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl JMed 2002;347:233-39.

95. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22.

96. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum anti­microbial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003;3:201-13.

97. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127:817-26.

98. Beardsall K, Thompson MH, Mulla RJ. Neonatal group B strepto­coccal infection in South Bedfordshire, 1993-1998. Arch Dis Child Fetal Neonatal Ed 2000;82:F205-7.

99. Health Protection Agency (HPA). Rise in New Diagnoses of Sexually Transmitted Infections in the United Kingdom in 2009. London: HPA; 2010.

100. Health Protection Agency (HPA). All New Episodes Seen at GUM Clinics: 1998-2007. United Kingdom and Country Specific Tables. London: HPA; 2008.

101. Carey J. Gonorrhoea in maternal medicine and infections. In: Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D (eds), Oxford Desk Reference Obstetrics and Gynaecology, pp. 218-19. Oxford: Oxford University Press; 2011.

102. Brocklehurst P. Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev 2002;2:CD000098.

103. Witzeman K. Syphilis in maternal medicine and infec­tions. In: Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D (eds), Oxford Desk Reference Obstetrics and Gynaecology, pp. 306-308. Oxford: Oxford University Press; 2011.

104. Public Health England. Sexually transmitted infections and chla­mydia screening in England, 2013. Health Protection Report. 2014. Available at: https://webarchive.nationalarchives.gov.uk/ 20140714084352/http:/www.hpa.org.uk/hpr/archives/2014/ hpr2414_AA_stis.pdf.

105. Khare MM, Khare MD. Infections in pregnancy. In: Greer I, Nelson-Piercy C, Walters B (eds), Maternal Medicine: Medical Problems in Pregnancy, pp. 217-35. London: Elsevier Ltd; 2007.

106. Allstaff S, Wilson J. The management of sexually transmitted in­fections in pregnancy. TOG 2012;14:25-32.

107. De Santis M, De Luca C, Mappa I, et al. Syphilis infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol 2012;2012:430585.

108. Narayan H. Syphilis in maternal infections. In: Compendium for the Antenatal Care of High-R isk Pregnancies, pp. 102-103. Oxford: Oxford University Press; 2015.

109. Hof H. History and epidemiology of listeriosis. FEMS Immunol Med Microbiol 2003;35:199-202.

110. Janakiraman V Listeriosis in pregnancy: diagnosis, treatment, and prevention. Rev Obstet Gynecol 2008;1:179-85.

111. Gilbert GL. Infections in pregnant women. Med J Aust 2002;176:229-36.

112. Heinrichs G. Listeriosis in maternal medicine and infections. In: Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D (eds), Oxford Desk Reference Obstetrics and Gynaecology, pp. 272-73. Oxford: Oxford University Press; 2011.

113. Temple ME, Nahata MC. Treatment of listeriosis. Ann Pharmacother 2000;34:656-61.

114. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epi­demiology and outcome. Obstet Gynecol Surv 2002;57:245-56.

115. Gibbs R. Cytomegalovirus in maternal medicine and infec­tions. In: Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D (eds), Oxford Desk Reference Obstetrics and Gynaecology, pp. 197-97. Oxford: Oxford University Press; 2011.

116. Narayan H. Cytomegalovirus in maternal infections. In: Compendium for the Antenatal Care of High-Risk Pregnancies, pp. 67-69. Oxford: Oxford University Press; 2015.

117. Society of Obstetricians and Gynaecologists of Canada (SOGC). Cytomegalovirus Infection in Pregnancy. Clinical Practice Guideline No. 240. Ottawa: SOGC; 2010.

118. Adler SP. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011;2011:942937.

119. McCarthy FP, Jones C, Rowlands S, Giles M. Primary and sec­ondary cytomegalovirus in pregnancy. TOG 2009;11:96-100.

120. Alston M. Rubella in maternal medicine and infections. In: Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D (eds), Oxford Desk Reference Obstetrics and Gynaecology, pp. 302-303. Oxford: Oxford University Press; 2011.

121. Marret H, Golfier F, Di Maio M, Champion F, Attia-Sobol J, Raudrant D. Rubella in pregnancy. Management and prevention. Presse Med 1999;28:2117-22.

122. World Health Organization. Measles. Fact sheet. November 2016. Available at: http://www.who.int/mediacentre/factsheets/ fs286/en/.

123. Stiglich N. Measles: rubeola in maternal medicine and infec­tions. In: Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D (eds), Oxford Desk Reference Obstetrics and Gynaecology, pp. 278-79. Oxford: Oxford University Press; 2011.

124. Narayan H. Parvovirus in Maternal infections. In: Compendium for the Antenatal Care of High-Risk Pregnancies, pp. 99-100. Oxford: Oxford University Press; 2015.

125. To M, Kidd M, Maxwell D. Prenatal diagnosis and management of fetal infections. TOG 2009;11:108-16.

126. Royal College of Obstetricians and Gynaecologists (RCOG) Safety and Quality Committee. Parvovirus in Pregnancy. Safety Alert No. 3. London: RCOG; 2012.

127. Miranda-Seijo P. Parvovirus in maternal medicine and infec­tions. In: Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D (eds), Oxford Desk Reference Obstetrics and Gynaecology, p. 280. Oxford: Oxford University Press; 2011.

128. Royal College of Obstetricians and Gynaecologists (RCOG). Management of Genital Herpes in Pregnancy. Green-top Guideline No. 30. London: RCOG; 2007.

129. Public Health England. Varicella: The Green Book, Chapter 34. London: Public Health England; 2012. Available at: https://www.gov.uk/government/publications/varicella-the- green-book-chapter-34.

130. Royal College of Obstetricians and Gynaecologists (RCOG). Chickenpox in Pregnancy. Green-top Guideline No. 13. London: ROCG; 2007.

131. World Health Organization. Hepatitis B. Fact sheet. Updated July 2016. Available at: http://www.who.int/mediacentre/factsheets/ fs204/en/.

132. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-spe­cific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-71.

133. Forton D, Gess M. Hepatitis B in maternal medicine and infec­tions. In: Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D (eds), Oxford Desk Reference Obstetrics and Gynaecology, pp. 238-41. Oxford: Oxford University Press; 2011.

134. Di Bisceglie AM. Hepatitis C. Lancet 1998;351:351-55.

135. Center for Disease Control and Prevention. Recommendations for prevention and control of hepatitis c virus (HCV) infec­tion and HCV-related chronic disease. MMWR Recomm Rep 1998;47:1-39.

136. Pembrey L, Newell ML, Tovo PA. Antenatal hepatitis C virus screening and management of infected women and their chil­dren: policies in Europe. Eur J Pediatr 1999:158:842-46.

137. European Paediatric Hepatitis C Virus Network. A significant sex—but not elective cesarean section—effect on mother- to-child transmission of hepatitis C virus infection. JID 2005:192:1872-79.

138. Bull L, Khan AW, Barton S. Management of HIV infection in pregnancy. Obstet Gynaecol Reprod Med 2015;25, 10:273-78.

139. World Health Organization. 10 facts on HIV/AIDS. Updated November 2016. Available at: http://www.who.int/features/ factfiles/hiv/en/.

140. Lack N. HIV in pregnancy. In: Bhide A, Divakar H, Arulkumaran S (eds), Handbook of Obstetrics and Gynaecology for Asia and Oceania, pp. 216-20. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2016.

141. Joynson DH. Epidemiology of toxoplasmosis in the UK. Scand J Infect Dis Suppl 1992;84:65-69.

142. 'Thulliez P. Maternal and fetal infection. In: Joynson DHM, Wreghitt TG (eds), Toxoplasmosis: A Comprehensive Clinical Guide, pp. 193-213. Cambridge: Cambridge University Press; 2001.

143. Desmonts G, Couvreur J. Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy. Ann Pediatr (Paris) 1984;31:805-809.

144. Antsaklis A, Daskalakis G, Papantoniou N, Mentis A, Michalas S. Prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn 2002;22:1107-11.

145. Foulon W, Pinon JM, Stray-Pedersen B, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 1999;181:843-47.

146. Wong SY, Remington JS. Biology of Toxoplasma gondii. AIDS 1993;7:299-316.

147. McCabe RE. Antitoxoplasma chemotherapy. In: Joynson DHM, Wreghitt TG (eds), Toxoplasmosis: A Comprehensive Clinical Guide, pp. 319-59. Cambridge: Cambridge University Press; 2001.